Reports for TEVA-SUCRALFATE

Brand name

TEVA-SUCRALFATE
Company Name
TEVA CANADA LIMITED
Drug Identification Number
02045702
Ingredients
SUCRALFATE
Ingredient Strength
1 G
ATC Code
A02BX
A02BX
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Status
MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
TEVA-SUCRALFATE 500 Resolved 2023-08-17 2023-10-04 202228
TEVA-SUCRALFATE 100 Resolved 2022-06-09 2022-09-08 162303
TEVA-SUCRALFATE 500 Resolved 2023-02-16 2023-06-09 184934
TEVA-SUCRALFATE 500 Resolved 2023-06-16 2023-07-21 195039
TEVA-SUCRALFATE 100 Resolved 2023-06-16 2023-10-04 195055
TEVA-SUCRALFATE 500 Resolved 2023-07-27 2023-08-04 200210
TEVA-SUCRALFATE 100 Resolved 2024-03-07 2024-05-30 221540
TEVA-SUCRALFATE 100's & 500's Actual shortage 2025-05-05 2025-05-08 256702
TEVA-SUCRALFATE 500 Resolved 2024-08-30 2024-11-08 236362
TEVA-SUCRALFATE 100 Resolved 2022-01-27 2022-02-25 153727

Showing 1 to 10 of 22

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0